chr3-54918855-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020678.4(LRTM1):c.642C>A(p.Asp214Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000128 in 1,567,994 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020678.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRTM1 | NM_020678.4 | c.642C>A | p.Asp214Glu | missense_variant | 3/3 | ENST00000273286.6 | NP_065729.1 | |
CACNA2D3 | NM_018398.3 | c.2449+18987G>T | intron_variant | ENST00000474759.6 | NP_060868.2 | |||
LRTM1 | NM_001304389.2 | c.414C>A | p.Asp138Glu | missense_variant | 3/3 | NP_001291318.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152190Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000138 AC: 3AN: 217424Hom.: 0 AF XY: 0.0000171 AC XY: 2AN XY: 116744
GnomAD4 exome AF: 0.0000127 AC: 18AN: 1415804Hom.: 0 Cov.: 32 AF XY: 0.0000172 AC XY: 12AN XY: 698252
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152190Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 25, 2024 | The c.642C>A (p.D214E) alteration is located in exon 3 (coding exon 3) of the LRTM1 gene. This alteration results from a C to A substitution at nucleotide position 642, causing the aspartic acid (D) at amino acid position 214 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at